Racial disparities in cardiovascular manifestations among patients with sickle cell trait: analysis of national

Praneeth Reddy Keesari1, Charan Thej Reddy Vegivinti2, Medha Rajamanuri3

  • 1Department of Internal Medicine, Staten Island University Hospital, Staten Island, NY, USA.

Annals of Hematology
|March 20, 2025
PubMed

Insights

Sickle cell trait (SCT) affects millions, with African Americans disproportionately impacted. This study found higher odds of acute heart failure in African Americans with SCT, highlighting an understudied cardiovascular risk.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Public Health

Background:

  • Sickle cell trait (SCT) affects millions, including 10% of African Americans in the U.S.
  • SCT is often considered benign, but its full health burden and racial disparities are understudied.
  • Limited data exists on cardiovascular risk in African Americans with SCT compared to other racial groups.

Purpose of the Study:

  • To investigate cardiovascular outcomes in African Americans with SCT.
  • To compare cardiovascular risk in African Americans with SCT versus other racial groups.

Main Methods:

  • Utilized the National Inpatient Sample (NIS) database for analysis.
  • Compared cardiovascular outcomes between African Americans with SCT and other racial groups.

Main Results:

  • African Americans with SCT showed statistically significant higher odds of acute heart failure.
  • Adjusted Odds Ratio (OR) for acute heart failure in African Americans with SCT was 1.39 (p < 0.01, 95% CI: 1.13-1.71).

Conclusions:

  • African Americans with SCT may face increased cardiovascular risk, specifically for acute heart failure.
  • Further research is needed to understand racial disparities and causal effects of SCT on cardiovascular health.

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
254
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
33.9K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.0K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
40